Third Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland.
Am J Cardiol. 2012 Jan 15;109(2):208-13. doi: 10.1016/j.amjcard.2011.08.026. Epub 2011 Oct 12.
The aim of the present study was to evaluate the effect of concurrent chronic total occlusion (CTO) in a noninfarct-related artery (IRA) on the long-term prognosis in patients with ST-segment elevation myocardial infarction and multivessel coronary disease. Of 1,658 consecutive patients with ST-segment elevation myocardial infarction, 666 with multivessel coronary disease who underwent percutaneous coronary intervention from 1999 to 2004 were included in the present analysis. The patients were divided into 2 groups: no CTO and CTO. The first group included 462 patients without CTO (69%) and the second group included 204 patients with CTO in a non-IRA (31%). The in-hospital mortality rate was 6.3% and 21.1% (p < 0.0001) and the 5-year mortality rate was 22.5% and 40.2% (p < 0.0001) for the no-CTO and CTO patients, respectively. Multivariate analysis revealed that after correction for baseline differences CTO in a non-IRA was a strong, independent predictor of 5-year mortality in patients undergoing percutaneous coronary intervention (hazard ratio 1.85; 95% confidence interval 1.35 to 2.53; p = 0.0001). In conclusion, the presence of CTO in a non-IRA in patients with ST-segment elevation myocardial infarction and multivessel coronary disease is a strong and independent risk factor for greater 5-year mortality.
本研究旨在评估非梗死相关动脉(IRA)中同时存在慢性完全闭塞(CTO)对伴有多支血管病变的 ST 段抬高型心肌梗死(STEMI)患者长期预后的影响。在 1658 例连续的 STEMI 患者中,纳入了 1999 年至 2004 年间接受经皮冠状动脉介入治疗的 666 例多支血管病变患者进行本分析。患者被分为 2 组:无 CTO 和 CTO。第一组包括 462 例无 CTO(69%)患者,第二组包括 204 例 IRA 外 CTO(31%)患者。住院死亡率分别为 6.3%和 21.1%(p<0.0001),5 年死亡率分别为 22.5%和 40.2%(p<0.0001)。多变量分析显示,校正基线差异后,IRA 外 CTO 是经皮冠状动脉介入治疗患者 5 年死亡率的一个强独立预测因素(危险比 1.85;95%置信区间 1.35 至 2.53;p=0.0001)。总之,STEMI 合并多支血管病变患者 IRA 外 CTO 的存在是 5 年死亡率更高的一个强而独立的危险因素。